Caramiphen
 | |
| Clinical data | |
|---|---|
| Trade names | Carafen |
| ATC code | None |
| Identifiers | |
| |
| CAS Number | 77-22-5 |
| PubChem (CID) | 6472 |
| ChemSpider | 6228 |
| ChEMBL | CHEMBL61946 |
| ECHA InfoCard | 100.000.922 |
| Chemical and physical data | |
| Formula | C18H27NO2 |
| Molar mass | 289.413 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
Caramiphen is an anticholinergic drug used in the treatment of Parkinson's disease.[1] In combination with phenylpropanolamine it is used as a cough suppressant and nasal decongestant to treat symptoms associated with respiratory illnesses such as cold, allergies, hay fever, and sinusitis.[2]
See also
- Metcaraphen
References
- ↑ "Caramiphen". drugs.com. Retrieved 26 September 2012.
- ↑ "Caramiphen with phenylpropanolamine-oral, Ordrine AT, Rescaps-D, Tuss Vernade, Tusso-Gest". medicine.net. Archived from the original on 29 October 2012. Retrieved 26 September 2012.
| Calcium (Ca2+) |
| ||||||
|---|---|---|---|---|---|---|---|
| Potassium (K+) |
| ||||||
| Sodium (Na+) |
| ||||||
| Chloride (Cl−) |
| ||||||
This article is issued from Wikipedia - version of the 11/14/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.